Which trial do we need? Defining the optimal duration of antifungal therapy for invasive pulmonary aspergillosis.

Saved in:
Bibliographic Details
Title: Which trial do we need? Defining the optimal duration of antifungal therapy for invasive pulmonary aspergillosis.
Authors: Desoubeaux G; Tours University Hospital, Parasitology-Mycology-Tropical Medicine, Tours, France; University of Tours, INSERM UMR1100 Centre d'étude des pathologies respiratoires (CEPR), School of Medicine, Tours, France. Electronic address: guillaume.desoubeaux@univ-tours.fr., Mikulska M; Division of Infectious Diseases, University of Genova, Genoa, Italy; IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Lemaignen A; Tours University Hospital, Department of Infectious Diseases, Tours, France., Gyan E; Tours University Hospital, Haematology and Cell Therapy, Tours, France; University of Tours, INSERM U1069 Niche, Nutrition, Cancer & Metabolism Oxydatif (N2Cox), Tours, France., Stemler J; Division of Infectious Diseases, Department of Internal Medicine, Excellence Center for Medical Mycology (ECMM), University Hospital Cologne, Cologne, Germany; Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine, University of Cologne, Cologne, Germany; Partner Site Bonn-Cologne, German Centre for Infection Research (DZIF), Cologne, Germany., Vanbiervliet Y; Department of Hematology, University Hospital Gasthuisberg, Leuven, Belgium; Department of Microbiology, Immunology, and Transplantation, KU Leuven, Leuven, Belgium., Maertens J; Department of Hematology, University Hospital Gasthuisberg, Leuven, Belgium; Department of Microbiology, Immunology, and Transplantation, KU Leuven, Leuven, Belgium., Lortholary O; Mycology Translational Research Group, Mycology Department, National Reference Center for Invasive Mycoses and Antifungals, Institut Pasteur, Université Paris Cité, Paris, France; Infectious Diseases and Tropical Medicine, Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France., Paccoud O; Mycology Translational Research Group, Mycology Department, National Reference Center for Invasive Mycoses and Antifungals, Institut Pasteur, Université Paris Cité, Paris, France; Infectious Diseases and Tropical Medicine, Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France., Slavin MA; Department of Infectious Diseases and National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Cornely OA; Division of Infectious Diseases, Department of Internal Medicine, Excellence Center for Medical Mycology (ECMM), University Hospital Cologne, Cologne, Germany; Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine, University of Cologne, Cologne, Germany; Partner Site Bonn-Cologne, German Centre for Infection Research (DZIF), Cologne, Germany., Neofytos D; Service des Maladies Infectieuses, Hôpitaux Universitaires de Genève, Geneva, Switzerland., Lanternier F; Mycology Translational Research Group, Mycology Department, National Reference Center for Invasive Mycoses and Antifungals, Institut Pasteur, Université Paris Cité, Paris, France; Infectious Diseases and Tropical Medicine, Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Source: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2026 May; Vol. 32 (5), pp. 683-686. Date of Electronic Publication: 2026 Feb 07.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9516420 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1469-0691 (Electronic) Linking ISSN: 1198743X NLM ISO Abbreviation: Clin Microbiol Infect Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41662953
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Which trial do we need? Defining the optimal duration of antifungal therapy for invasive pulmonary aspergillosis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Desoubeaux+G%22">Desoubeaux G</searchLink>; Tours University Hospital, Parasitology-Mycology-Tropical Medicine, Tours, France; University of Tours, INSERM UMR1100 Centre d'étude des pathologies respiratoires (CEPR), School of Medicine, Tours, France. Electronic address: guillaume.desoubeaux@univ-tours.fr.<br /><searchLink fieldCode="AU" term="%22Mikulska+M%22">Mikulska M</searchLink>; Division of Infectious Diseases, University of Genova, Genoa, Italy; IRCCS Ospedale Policlinico San Martino, Genoa, Italy.<br /><searchLink fieldCode="AU" term="%22Lemaignen+A%22">Lemaignen A</searchLink>; Tours University Hospital, Department of Infectious Diseases, Tours, France.<br /><searchLink fieldCode="AU" term="%22Gyan+E%22">Gyan E</searchLink>; Tours University Hospital, Haematology and Cell Therapy, Tours, France; University of Tours, INSERM U1069 Niche, Nutrition, Cancer & Metabolism Oxydatif (N2Cox), Tours, France.<br /><searchLink fieldCode="AU" term="%22Stemler+J%22">Stemler J</searchLink>; Division of Infectious Diseases, Department of Internal Medicine, Excellence Center for Medical Mycology (ECMM), University Hospital Cologne, Cologne, Germany; Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine, University of Cologne, Cologne, Germany; Partner Site Bonn-Cologne, German Centre for Infection Research (DZIF), Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Vanbiervliet+Y%22">Vanbiervliet Y</searchLink>; Department of Hematology, University Hospital Gasthuisberg, Leuven, Belgium; Department of Microbiology, Immunology, and Transplantation, KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Maertens+J%22">Maertens J</searchLink>; Department of Hematology, University Hospital Gasthuisberg, Leuven, Belgium; Department of Microbiology, Immunology, and Transplantation, KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Lortholary+O%22">Lortholary O</searchLink>; Mycology Translational Research Group, Mycology Department, National Reference Center for Invasive Mycoses and Antifungals, Institut Pasteur, Université Paris Cité, Paris, France; Infectious Diseases and Tropical Medicine, Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.<br /><searchLink fieldCode="AU" term="%22Paccoud+O%22">Paccoud O</searchLink>; Mycology Translational Research Group, Mycology Department, National Reference Center for Invasive Mycoses and Antifungals, Institut Pasteur, Université Paris Cité, Paris, France; Infectious Diseases and Tropical Medicine, Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.<br /><searchLink fieldCode="AU" term="%22Slavin+MA%22">Slavin MA</searchLink>; Department of Infectious Diseases and National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Cornely+OA%22">Cornely OA</searchLink>; Division of Infectious Diseases, Department of Internal Medicine, Excellence Center for Medical Mycology (ECMM), University Hospital Cologne, Cologne, Germany; Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine, University of Cologne, Cologne, Germany; Partner Site Bonn-Cologne, German Centre for Infection Research (DZIF), Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Neofytos+D%22">Neofytos D</searchLink>; Service des Maladies Infectieuses, Hôpitaux Universitaires de Genève, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Lanternier+F%22">Lanternier F</searchLink>; Mycology Translational Research Group, Mycology Department, National Reference Center for Invasive Mycoses and Antifungals, Institut Pasteur, Université Paris Cité, Paris, France; Infectious Diseases and Tropical Medicine, Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229516420%22">Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</searchLink> [Clin Microbiol Infect] 2026 May; Vol. 32 (5), pp. 683-686. <i>Date of Electronic Publication: </i>2026 Feb 07.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9516420 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1469-0691 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221198743X%22">1198743X </searchLink><i>NLM ISO Abbreviation: </i>Clin Microbiol Infect <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41662953
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.cmi.2026.01.030
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 683
    Titles:
      – TitleFull: Which trial do we need? Defining the optimal duration of antifungal therapy for invasive pulmonary aspergillosis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Desoubeaux G
      – PersonEntity:
          Name:
            NameFull: Mikulska M
      – PersonEntity:
          Name:
            NameFull: Lemaignen A
      – PersonEntity:
          Name:
            NameFull: Gyan E
      – PersonEntity:
          Name:
            NameFull: Stemler J
      – PersonEntity:
          Name:
            NameFull: Vanbiervliet Y
      – PersonEntity:
          Name:
            NameFull: Maertens J
      – PersonEntity:
          Name:
            NameFull: Lortholary O
      – PersonEntity:
          Name:
            NameFull: Paccoud O
      – PersonEntity:
          Name:
            NameFull: Slavin MA
      – PersonEntity:
          Name:
            NameFull: Cornely OA
      – PersonEntity:
          Name:
            NameFull: Neofytos D
      – PersonEntity:
          Name:
            NameFull: Lanternier F
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2026 May
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1469-0691
          Numbering:
            – Type: volume
              Value: 32
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
              Type: main
ResultId 1